Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Pancreatic Ductal × Irinotecan × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 62 Pancreatic Neoplasms 29 Neoplasm Metastasis 20 Neuroblastoma 16 Colonic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 13 Rectal Neoplasms 9 Sarcoma, Ewing 8 Rhabdomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Ovarian Neoplasms 6 Sarcoma 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Medulloblastoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Recurrence 3 Osteosarcoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Ependymoma 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 Cetuximab 3 Bevacizumab 3 pembrolizumab 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 relacorilant 1 Long Interspersed Nucleotide Elements 1 Immunotherapy, Adoptive 1 Floxuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡